FDA Inspection 1048712 — Catalent Germany Eberbach GmbH
The FDA completed an inspection of Catalent Germany Eberbach GmbH on Mar 2, 2018 in Eberbach. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 2, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Eberbach (Germany)